| Host: |
Rabbit |
| Applications: |
IF/ELISA |
| Reactivity: |
Human/Rat/Mouse |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-Lymphocyte antigen 6E (17-66 aa) is suitable for use in Immunofluorescence and ELISA research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
| Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Concentration: |
1 mg/mL |
| Dilution Range: |
IF 1:200-1:1000ELISA 1:20000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
LY6E |
| Gene ID: |
4061 |
| Uniprot ID: |
LY6E_HUMAN |
| Immunogen Region: |
17-66 aa |
| Specificity: |
TSA-1 Polyclonal Antibody detects endogenous levels of TSA-1 protein. |
| Immunogen: |
The antiserum was produced against synthesized peptide derived from the human LY6E at the amino acid range 17-66 |
| Function | GPI-anchored cell surface protein that regulates T-lymphocytes proliferation, differentiation, and activation. Regulates the T-cell receptor (TCR) signaling by interacting with component CD3Z/CD247 at the plasma membrane, leading to CD3Z/CD247 phosphorylation modulation. Restricts the entry of human coronaviruses, including SARS-CoV, MERS-CoV and SARS-CoV-2, by interfering with spike protein-mediated membrane fusion. Also plays an essential role in placenta formation by acting as the main receptor for syncytin-A (SynA). Therefore, participates in the normal fusion of syncytiotrophoblast layer I (SynT-I) and in the proper morphogenesis of both fetal and maternal vasculatures within the placenta. May also act as a modulator of nicotinic acetylcholine receptors (nAChRs) activity. (Microbial infection) Promotes entry, likely through an enhanced virus-cell fusion process, of various viruses including HIV-1, West Nile virus, dengue virus and Zika virus. In contrast, the paramyxovirus PIV5, which enters at the plasma membrane, does not require LY6E. Mechanistically, adopts a microtubule-like organization upon viral infection and enhances viral uncoating after endosomal escape. |
| Protein Name | Lymphocyte Antigen 6eLy-6eRetinoic Acid-Induced Gene E ProteinRig-EStem Cell Antigen 2Sca-2Thymic Shared Antigen 1Tsa-1 |
| Database Links | Reactome: R-HSA-163125 |
| Cellular Localisation | Cell MembraneLipid-AnchorGpi-Anchor |
| Alternative Antibody Names | Anti-Lymphocyte Antigen 6e antibodyAnti-Ly-6e antibodyAnti-Retinoic Acid-Induced Gene E Protein antibodyAnti-Rig-E antibodyAnti-Stem Cell Antigen 2 antibodyAnti-Sca-2 antibodyAnti-Thymic Shared Antigen 1 antibodyAnti-Tsa-1 antibodyAnti-LY6E antibodyAnti-9804 antibodyAnti-RIGE antibodyAnti-SCA2 antibodyAnti-TSA1 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
